In the cost-constrained healthcare systems, the costs of high premium innovative drugs are putting severe financial pressure on health authorities. Strategic Perspectives 2002: Colorectal Cancer Cost Analysis details the cost of various treatment regimens used in colorectal cancer and the implications on their reimbursement status, enabling you to: ·Identify the key factors in gaining reimbursement status for a new drug in the colorectal cancer market ·Enhance your product’s commercial viability by making detailed comparative analysis of the strategies used by the current players in the market ·Determine the key products in the colorectal cancer market in the future and the cost implications for these products.
